Close Menu

Cancer in His Sights

In a series, the New York Times profiles the work of Keith Flaherty, an oncologist at the University of Pennsylvania, who has evangelized a targeted approach to treating cancer. The first part follows the highs and lows of clinical trials after Flaherty jumped headlong into testing drugs targeting B-RAF mutations in cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

NPR reports that some insect pests are now becoming resistant to Bt crops.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.